Sunshine Biopharma closes $6 million public offering, issues Series D warrants for up to $14.4 million proceeds

Sunshine Biopharma closed a public offering raising about $6 million in gross proceeds. The offering included warrants that could generate about $14.4 million in additional gross proceeds if fully exercised for cash.